期刊文献+

32例三阴乳腺癌患者的临床病理特征及预后因素分析 被引量:1

下载PDF
导出
摘要 目的探讨32例三阴乳腺癌患者的临床病理特征及预后因素。方法收集32例三阴乳腺癌患者,设置为观察组,并收集同期实施体检的非三阴乳腺癌患者,设置为对照组。对于所有患者在临床上出现的病理特征进行相应的分析,找出所有患者的临床病理特征及预后因素。结果观察组患者年龄明显低于对照组,大肿块发生率和脉管转移率均明显的高于对照组患者(P<0.05)差异有统计学意义。结论三阴乳腺癌患者发病年龄较小,同时其侵袭性较强,在临床上主要独立预后因素为患者的年龄、淋巴结转移率,需要对其进行严格的重视。
作者 黄丽红 舒畅
出处 《中国医药指南》 2015年第25期168-168,共1页 Guide of China Medicine
  • 相关文献

参考文献5

二级参考文献59

  • 1Rakha EA, El-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer [ J ] . Cancer, 2007, 109(1): 25-32.
  • 2Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: Clinical features and patterns of recurrence [ J ] . Clin Cancer Res, 2007, 13(15):4429-4434.
  • 3Chang JC, Wooten EC, Tsimelzon A, et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer [ J ] . Lancet, 2003, 362(9381): 362-369.
  • 4Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours [ J ] . Nature, 2000, 406(6797): 747- 752.
  • 5Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets [ J ] . Proc Natl Acad Sci USA, 2003, 100(14): 8418- 8423.
  • 6Rouzier R, Perou CM, Symmans WF, et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy [J ] . Clin Cancer Res, 2005, 11(16): 5678- 5685.
  • 7Carey LA, Dees EC, Sawyer L, et al. The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes [ J ] . Clin Cancer Res, 2007, 13(8): 2329-2334.
  • 8Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer [ J ] . J Clin Oncol, 2008, 26(8): 1275-1281.
  • 9Livasy CA, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma [ J ] . Mod Pathol, 2006, 19(2): 264-271.
  • 10Siziopikou KP, Ariga R, Proussaloglou KE, et al. The challenging estrogen receptor-negative/ progesterone receptor-negative/HER-2-negative patient: A promising candidate for epidermal growth factor receptor-targeted therapy? [ J ] . Breast J, 2006, 12(4): 360-362.

共引文献207

同被引文献9

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部